← Back
$VIR All transactions

Vir Biotechnology, Inc.

▼ SELL 10b5-1 Plan

$ Value

$142K

Shares

19,039

Price

$7

Filed

Feb 24

Insider

Name

De Backer Marianne

Title

Chief Executive Officer

CIK

0001797819

Roles

Director Officer

Transaction Details

Transaction Date

2026-02-23

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

1,035,466

Footnotes

Acquisition of restricted stock units (RSUs) pursuant to the Issuer's Equity Incentive Plan. | Represents an automatic and mandatory sale of shares under a Rule 10b5-1 arrangement to satisfy the Issuer's tax withholding obligations in connection with the vesting of RSUs. The sale does not represent a discretionary trade by the Reporting Person. | The shares are held in the name of the Ureel-De Backer Family Trust, of which the Reporting Person and her spouse are Trustees. | 25% of the shares subject to the stock option will vest and become exercisable on February 22, 2027, and the remaining shares will vest in 36 equal monthly installments thereafter.

Filing Info

Accession No.

0001628280-26-011327

Form Type

4

Issuer CIK

0001706431

De Backer Marianne's History

Date Ticker Type Value
2026-04-06 VIR $664K
2026-02-24 VIR $141K
2026-02-23 VIR $142K
2026-02-22 VIR A $0
2026-02-22 VIR A $0

Other Insiders at VIR (90d)

Insider Bought Sold Last
SATO VICKI L $992K 2026-04-01
De Backer Marianne
Chief Executive Officer
$141K 2026-02-24
De Backer Marianne
President and CEO
$664K 2026-04-06
Eisner Mark
EVP and Chief Medical Officer
$50K 2026-02-25
O'Byrne Jason
EVP & Chief Financial Officer
$31K 2026-03-20
de Verneuil Vanina
EVP, General Counsel, Corp Sec
$197K 2026-02-25
Sabatini Brent
SVP, Chief Accounting Officer
$110K 2026-03-23